Affimed NV News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Affimed NV AFMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 2.7% 3.80 20:00:00
Close Price Low Price High Price Open Price Previous Close
3.80 3.69 3.88 3.75 3.70
more quote information »

Recent News

Date Time Source Heading
9/02/202006:30GLOBEAffimed to Present at Upcoming Investor Conferences
8/11/202006:33EDGARReport of Foreign Issuer (6-k)
8/11/202006:30GLOBEAffimed Reports Second Quarter 2020 Financial Results and ..
8/05/202007:00EDGARReport of Foreign Issuer (6-k)
8/05/202006:30GLOBEAffimed Announces Two New Appointments to Its Supervisory..
8/04/202006:30GLOBEAffimed to Report Second Quarter 2020 Financial Results &..
7/27/202016:37EDGARReport of Foreign Issuer (6-k)
7/10/202008:12EDGARReport of Foreign Issuer (6-k)
7/10/202006:30GLOBEAffimed Announces Annual General Meeting of Shareholders
6/23/202006:45EDGARReport of Foreign Issuer (6-k)
6/23/202006:30GLOBEAffimed Reports First Quarter 2020 Financial Results and..
6/22/202009:20GLOBEAffimed Announces Presentation of Data on Genentech’s..
6/17/202006:30GLOBEAffimed Announces Successful Completion of First Dose Cohort..
6/16/202010:56EDGARStatement of Ownership (sc 13g)
6/16/202006:30GLOBEAffimed to Report First Quarter 2020 Financial Results &..
6/11/202006:30GLOBEAffimed Announces Appointment of Angus Smith as Chief..
5/29/202008:05GLOBEAffimed Highlights Study Design of its AFM13 REDIRECT Trial..
5/28/202005:00GLOBEAffimed to Present at the Jefferies Virtual Healthcare..
5/26/202016:30EDGARStatement of Ownership (sc 13g)
5/15/202005:00GLOBEAffimed Announces Abstracts on Innate Cell Engagers from its..
5/13/202016:33EDGARReport of Foreign Issuer (6-k)
5/13/202016:32EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/08/202008:10EDGARSchedule 13g
4/28/202017:04EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
4/28/202006:49EDGARReport of Foreign Issuer (6-k)
4/28/202006:35GLOBEAffimed Reports 2019 Financial Results and Recent..
4/16/202007:30GLOBEAffimed Announces First Patient Successfully Dosed in..
4/02/202006:30GLOBEAffimed Provides COVID-19-Related Business Update and..
4/01/202016:01GLOBEAffimed Announces FDA Granted Orphan Drug Designation for..
3/26/202007:30GLOBEAffimed Announces Participation at Upcoming Virtual Investor..
3/17/202007:30GLOBEAffimed Announces Appointment of Arndt Schottelius, M.D...
2/19/202007:30GLOBEAffimed to Present at the SVB Leerink 9th Annual Global..
2/13/202016:19EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202008:51EDGARStatement of Ownership (sc 13g)
2/03/202007:38EDGARReport of Foreign Issuer (6-k)
2/03/202007:30GLOBEAffimed Mourns Passing of Chief Financial Officer Dr...
1/10/202006:30GLOBEAffimed Announces Appointment of Andreas Harstrick, M.D., as..
12/17/201907:30GLOBEAffimed Announces Addition to NASDAQ Biotechnology Index
11/19/201907:30GLOBEAffimed Reports Third Quarter 2019 Financial Results and..
11/14/201906:30GLOBEAffimed to Present at the Jefferies 2019 London Healthcare..
11/13/201916:10GLOBEAffimed Announces Closing of Public Offering of Common..
11/12/201916:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/08/201906:30GLOBEAffimed Announces Pricing of Public Offering of Common..
11/07/201917:12EDGARReport of Foreign Issuer (6-k)
11/07/201917:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/07/201916:11GLOBEAffimed Announces Proposed Public Offering of Common Shares
11/07/201916:01GLOBEAffimed Highlights Progress on NK Cell Engager Collaboration..
10/15/201906:30GLOBEAffimed Reports Progress on Key Clinical Development..
See more news about this stock »

Your Recent History
Affimed NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.